Silencing TCF4 Sensitizes Melanoma Cells to Vemurafenib Through Inhibiting GLUT3-Mediated Glycolysis

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials

(2020) Axel Hauschild et al.   EUROPEAN JOURNAL OF CANCER

Diagnostic and Prognostic Value of Glucose Transporters in Melanocytic Lesions

(2019) Kristen N. Ruby et al.   MELANOMA RESEARCH

TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer

(2019) Geun Taek Lee et al.   PLoS One

Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays

(2019) Zufeng Guo et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Epidemiology and Risk Factors of Melanoma

(2019) Stephanie Carr et al.   SURGICAL CLINICS OF NORTH AMERICA

The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes

(2019) Lazaro Hiram Betancourt et al.   Cancers

Glucose transporters in cancer - from tumor cells to the tumor microenvironment

(2018) Pierre-Benoit Ancey et al.   FEBS Journal

Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions

(2017) Maocai Yan et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Cumulative evidence for relationships between multiple variants in the VTI1A and TCF7L2 genes and cancer incidence

(2017) Min Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

Malignant Melanoma in African–Americans

(2017) Krishnaraj Mahendraraj et al.   MEDICINE

Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases

(2017) Miroslav Důra et al.   PATHOLOGY & ONCOLOGY RESEARCH

Glucose Transporter Regulation in Cancer: A Profile and the Loops

(2016) Mutong Zhao et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma

(2016) Alex Kim et al.   Expert Opinion on Drug Discovery

Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade

(2016) Florian Rambow et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

UVA-Irradiation Induces Melanoma Invasion via the Enhanced Warburg Effect

(2016) York Kamenisch et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A PGC1α-mediated transcriptional axis suppresses melanoma metastasis

(2016) Chi Luo et al.   NATURE

Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells

(2016) F Faião-Flores et al.   ONCOGENE

Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the β-Catenin/Tcf4 Interaction

(2016) Qinghao Zhang et al.   PLoS One

Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing

(2015) Maayan Salton et al.   Nature Communications

Vemurafenib-resistant BRAF selects alternative branch points different from its wild-type BRAF in intron 8 for RNA splicing

(2015) Masahiko Ajiro et al.   Cell and Bioscience

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma

(2014) Chong Sun et al.   NATURE

A Critical Role for the Wnt Effector Tcf4 in Adult Intestinal Homeostatic Self-Renewal

(2012) J. H. van Es et al.   MOLECULAR AND CELLULAR BIOLOGY

Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching

(2011) Ossia M. Eichhoff et al.   Pigment Cell & Melanoma Research

Axin downregulates TCF-4 transcription via β-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells

(2010) Lian-He Yang et al.   Molecular Cancer

The Role of LEF/TCF Factors in Neoplastic Transformation

(2008) Mohamed El-Tanani et al.   CURRENT MOLECULAR MEDICINE

Activating transcription factor 4

(2007) Kurosh Ameri et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY